LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research

LTI

PR91941

 

MUMBAI, India, Sept. 28, 2021 /PRNewswire=KYODO JBN/ --

 

   - Partnership to help decentralize clinical trials resulting in better and

faster outcomes

 

   Larsen & Toubro Infotech [https://www.lntinfotech.com/] (BSE: 540005) (NSE:

LTI), a global technology consulting and digital solutions company has entered

in a strategic partnership with eClinicalHealth Limited to accelerate digital

innovation in R&D Clinical Trials Management process for patient-centric drug

development. The partnership will help clients decentralize clinical trials

setting new benchmarks of excellence in clinical research space.

 

    The significance of the tie-up is based on the fact that 86 percent of

clinical studies are delayed* due to challenges in patient engagement – mainly

involving recruitment and retaining patients, which is a time consuming and

expensive process. The pandemic has further aggravated this challenge. It is in

this context that eClinicalHealth, which is focused on developing innovative

clinical trial solutions, launched cloud-based patient-centric SaaS solution,

Clinpal – which improves patient engagement for each clinical trial journey.  

 

   As part of this strategic partnership, LTI with its digital, technical and

life sciences domain capabilities, will help accelerate joint go-to-market

pursuits and faster deployment for Clinpal Adopters. The solution will make use

of exponential technologies such as analytics and AI to enhance patient

engagement and faster clinical studies.

 

   Archana Ramanakumar, EVP & Global Delivery Head – Life Sciences, Media,

Consumer & Technology, LTI commented: "At LTI, we are on a journey to drive

digital transformation for various aspects of clinical trials. Our endeavour

with eClinicalHealth partnership is to accelerate and streamline the enablement

of Decentralized Trials, to reduce patient burden and drive acceleration of

clinical trials. With this partnership we aim to accelerate the development and

deployment of eClinicalHealth's ClinPal platform in clinical trials for the

industry."

 

   Karl Landert, Chairman of the Board and CEO at eClinicalHealth said: "The

new normal world has put into limelight the benefits of a telemedicine

ecosystem for larger benefit of end-users. Clinical trials assume an important

function in development and improvement of treatment methods in order to

enhance patient's wellbeing, and De-Centralized Trials (DCT) have attained

highest order of patient preference. With our strategic partnership with LTI,

our aim is to further scale and simplify patient engagement."

 

   *Contemporary Clinical Trials Volume 66, March 2018,

https://doi.org/10.1016/j.cct.2018.01.003

 

   About LTI:

 

   LTI [https://www.lntinfotech.com/] (NSE: LTI) is a global technology

consulting and digital solutions Company helping more than 435 clients succeed

in a converging world. With operations in 31 countries, we go the extra mile

for our clients and accelerate their digital transformation with LTI's Mosaic

platform [https://www.lntinfotech.com/digital-platforms/mosaic/] enabling their

mobile, social, analytics, IoT and cloud journeys. Founded in 1997 as a

subsidiary of Larsen & Toubro Limited, our unique heritage gives us unrivalled

real-world expertise to solve the most complex challenges of enterprises across

all industries. Each day, our team of more than 36,000 LTItes enable our

clients to improve the effectiveness of their business and technology

operations and deliver value to their customers, employees and shareholders.

Find more at http://www.Lntinfotech.com or follow us at @LTI_Global.

 

   About eClinicalHealth:

 

   Headquartered in Scotland, eClinicalHealth Limited

[https://www.clinpal.com/], developers of the revolutionary Clinpal patient

engagement platform, was founded in early 2012 to provide innovative clinical

trial solutions. The company is committed to leading open and collaborative

innovation discussions about patient-centric clinical trial processes and

technology with pharmaceutical companies, CROs, and other service and

technology providers.

 

   Connect with LTI:

 

   Read our News [https://www.lntinfotech.com/news-events/] and Blogs

[https://www.lntinfotech.com/blogs/]

   Follow us on Twitter [https://twitter.com/LTI_Global] and LinkedIn

[https://www.linkedin.com/company/l&t-infotech]

   Like us on Facebook

[https://www.facebook.com/LarsenToubroInfotech/?hc_ref=SEARCH&fref=nf]

 

    Logo: https://mma.prnewswire.com/media/1044154/LTI_Logo.jpg

 

    Source: LTI

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中